Cardiac Dose Risk Stratification and Determinants of Radiation Exposure in Breast Cancer Patients Undergoing Advanced Radiotherapy
Cardiac Dose Risk Stratification and Determinants of Radiation Exposure
Keywords:
Breast Neoplasms, Cardiovascular Diseases, Radiotherapy, Heart, Radiation Dosage, Cardiotoxicity, Risk Assessment, Mastectomy, Treatment Outcome, Retrospective StudiesAbstract
Background: Cardiac exposure during breast cancer radiotherapy is one of the well-known causes of late cardiovascular morbidity. The present secondary analysis was conducted with the aim of stratifying the risk of exposure to cardiac radiations and defining clinical and treatment specific determinants of increased cardiac dose among patients with breast cancer using three-dimensional conformal radiotherapy (3D-CRT). Methods: The treatment planning data of 126 female breast cancer patients given 3D-CRT in a tertiary cancer center was performed by secondary analysis. The Cardiac exposure was classified as being of low-, moderate-, and high-dose groups depending on clinically significant mean heart dose (MHD) exposure thresholds. The chi-square test, independent t-tests, and one-way ANOVA were used to test associations between cardiac dose category, laterality, surgical procedure and patient age with the level of statistical significance (p<0.05). Results: In general, patients who were classified within the moderate-high levels of cardiac exposure were 38.1%. The association between cardiac dose risk and left-sided breast cancer was significant as more than 85% of all the high-risk patients were identified to have left-sided treatment (p < 0.001). The type of surgery influences cardiac exposure since radical mastectomy was found to have a higher dose of risk than breast-conserving surgery (p < 0.001). Conclusion: This secondary review illustrates that there is no homogeneous distribution of cardiac radiation exposure during 3D-CRT but highly dependent on the tumor laterality and method of surgery as opposed to patient age.
Downloads
References
1. Smolarz B, Nowak AZ, Romanowicz H. Breast cancer—epidemiology, classification, pathogenesis and treatment (review of literature). Cancers. 2022 May 23;14(10):2569. https://doi.org/10.3390/cancers14102569
2. Koka K, Verma A, Dwarakanath BS, Papineni RV. Technological advancements in external beam radiation therapy (EBRT): An indispensable tool for cancer treatment. Cancer Manag Res. 2022 Apr 11;14:1421–1429. https://doi.org/10.2147/CMAR.S351744
3. Mohan S, Chopra V. Biological effects of radiation. In: Radiation dosimetry phosphors. Cambridge: Woodhead Publishing; 2022. p. 485–508. https://doi.org/10.1016/B978-0-323-85471-9.00006-3
4. Badiyan SN, Puckett LL, Vlacich G, Schiffer W, Pedersen LN, Mitchell JD, et al. Radiation-induced cardiovascular toxicities. Curr Treat Options Oncol. 2022 Oct;23(10):1388–1404. https://doi.org/10.1007/s11864-022-01012-9
5. Racka I, Majewska K, Winiecki J. Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold technique in left-sided breast cancer patients—comparative analysis of dose distribution and estimation of projected secondary cancer risk. Strahlenther Onkol. 2023 Jan;199(1):90–101. https://doi.org/10.1007/s00066-022-01979-2
6. Konstantinou E, Varveris A, Solomou G, Antoniadis C, Tolia M, Mazonakis M. Radiation dose to critical cardiac structures from three-dimensional conformal radiation therapy, intensity-modulated radiation therapy and volumetric modulated arc therapy techniques for left-sided breast cancer. J Pers Med. 2024 Jan;14(1):63. https://doi.org/10.3390/jpm14010063
7. Tao Y, Lu J, Deng W, Ma R, Tang S, Wei Y, et al. Correlation of mean heart dose and cardiac biomarkers with electrocardiographic changes in patients receiving thoracic radiation therapy. Radiat Res. 2023 Apr;199(4):336–345. https://doi.org/10.1667/RADE-22-00135.1
8. Bowen Jones S, Marchant T, Saunderson C, McWilliam A, Banfill K. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity. J Med Imaging Radiat Oncol. 2024 Dec;68(8):974–986. https://doi.org/10.1111/1754-9485.13737
9. De Kerf G, Claessens M, Raouassi F, Mercier C, Stas D, Ost P, et al. A geometry- and dose-volume–based performance monitoring of artificial intelligence models in radiotherapy treatment planning for prostate cancer. Phys Imaging Radiat Oncol. 2023 Oct;28:100494. https://doi.org/10.1016/j.phro.2023.100494
10. Wu S, Lin SX, Wirth GJ, Subtelny AO, Lu M, Lu J, et al. The clinical significance of the positive surgical margin and dominant tumor laterality following radical prostatectomy: A retrospective study. J Clin Transl Pathol. 2022 Dec 28;2(4):143–148. https://doi.org/10.14218/JCTP.2022.00023
11. Bi P. Integrating formative self-assessment into mobile L2 reading based on rotated component matrix analysis using SPSS 26.0. In: Proc IEEE Int Conf Educ Inf Manag Serv Sci (EIMSS); 2021 Jul 16; p. 546–549. https://doi.org/10.1109/EIMSS53851.2021.00122
12. Ferini G, Valenti V, Viola A, Umana GE, Martorana E. Predictors of heart sparing by deep-inspiration breath-hold irradiation in left-sided breast cancer patients: A critical overview. Cancers. 2022 Jul 18;14(14):3477. https://doi.org/10.3390/cancers14143477
13. Zureick AH, Grzywacz VP, Almahariq MF, Silverman BR, Vayntraub A, Chen PY, et al. Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer. Int J Radiat Oncol Biol Phys. 2022 Sep;114(1):130–139. https://doi.org/10.1016/j.ijrobp.2022.04.019
14. Lin H, Sheng X, Liu H, Zhang P, Liu Y, Zang C. Dosimetry of IMRT and VMAT techniques after modified radical mastectomy for breast cancer and hypofractionated IMRT. J Cancer Res Ther. 2023 Dec;19(6):1568–1574. https://doi.org/10.4103/jcrt.jcrt_51_23
15. Morsi NM, Mohamed RH, Ahmed NH, Fayed AA. Ultra-hypofractionated adjuvant radiotherapy for early invasive breast cancer. Cuest Fisioter. 2024 Nov;53(3):6590–6602. https://doi.org/10.48047/3040gm94
16. Ger RB, Wei L, El Naqa I, Wang J. The promise and future of radiomics for personalized radiotherapy dosing and adaptation. Semin Radiat Oncol. 2023 Jul;33(3):252–261. https://doi.org/10.1016/j.semradonc.2023.03.003
17. Riou O, Prunaretty J, Michalet M. Personalizing radiotherapy with adaptive radiotherapy: Interest and challenges. Cancer Radiother. 2024 Nov;28(6–7):603–609. https://doi.org/10.1016/j.canrad.2024.07.007
18. Salvestrini V, Valzano M, Meattini I, Becherini C, Visani L, Francolini G, et al. Anatomical assessment of local recurrence site after breast reconstruction and post-mastectomy radiotherapy. Radiol Med. 2024 Jun;129(6):845–854. https://doi.org/10.1007/s11547-024-01812-z
19. Bello U, Ibrahim H. Dosimetric influence of normalization points on post-mastectomy chest wall teletherapy. Saudi J Med. 2022 Nov;7(11):566–572. https://doi.org/10.36348/sjm.2022.v07i11.003
20. Parvej M, Cappelletto C, Caroli A, Vinante L, Drigo A, Chiovati P. Comparative analysis of radiotherapy modalities for left breast cancer with patient-specific DIBH selection criteria. Radiol Phys Technol. 2025 Jun;18(2):417–424. https://doi.org/10.1007/s12194-025-00891-5
21. Galimzhanov A, Istanbuly S, Tun HN, Ozbay B, Alasnag M, Ky B, et al. Cardiovascular outcomes in breast cancer survivors: A systematic review and meta-analysis. Eur J Prev Cardiol. 2023 Dec;30(18):2018–2031. https://doi.org/10.1093/eurjpc/zwad243
22. Wang SY, Tsai WT, Lin KH, Yu CW, Yang SY, Shueng PW, et al. Integrating subvolume dose and myocardial perfusion imaging to assess radiation impact on heart function in breast cancer. Thorac Cancer. 2023 Sep;14(26):2696–2706. https://doi.org/10.1111/1759-7714.15056
23. Shen J, Gu P, Wang Y, Wang Z. Advances in automatic delineation of target volume and cardiac substructures in breast cancer radiotherapy. Oncol Lett. 2023 Feb;25(3):110. https://doi.org/10.3892/ol.2023.13697
24. Wang Y, Zhang Y, Chen SY, Lv T, Liu Y, Fang H, et al. Personalized data-driven CT generation for patient selection in deep inspiration breath-hold breast radiotherapy. Phys Med. 2025 May;133:104964. https://doi.org/10.1016/j.ejmp.2025.104964
25. Zong X, Zhu L, Wang Y, Wang J, Gu Y, Liu Q. Cohort studies and multi-omics approaches to low-dose ionizing radiation–induced cardiovascular disease. Cardiovasc Toxicol. 2025 Jan;25(1):148–165. https://doi.org/10.1007/s12012-024-09943-5
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iqra Iftikhar (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
